Salivary growth factors in health and disease.
The salivary gland is considered to be a reservoir of many growth factors in rodents. In humans, the epidermal growth factor, basic fibroblast growth factor, and insulin and insulin-like growth factor family have also been detected in this gland, but their physiological role remains unclear. In this study, we focused on bFGF, which is a well-known mitogen for various types of cells, and is present in the salivary gland as well as in saliva. The roles of bFGF in the salivary gland were investigated by three different procedures. First, the effects of bFGF on the salivary gland cells were investigated with a monolayer culture of normal submandibular gland cells. The effects of different concentrations of bFGF on the second passage of these cultured cells were examined. In both human and rat cultured submandibular gland cells, bFGF accelerated the cell proliferation at a concentration of 100 ng/mL or higher. Next, an atrophic model of the rat submandibular gland was used to examine the ability of bFGF to accelerate tissue repair. Two weeks after ductal ligation, the ligature was removed, and various amounts of bFGF, isoproterenol, or saline were administered via a retrograde duct instillation. Both isoproterenol and bFGF increased acinar and ductal cell proliferation significantly. To determine the role of bFGF in saliva, we investigated its effect on the healing process of oral mucosal defects. Four-millimeter mucosal defects were made to the depth of the periosteum in the rat palate under anesthesia. bFGF or vehicle alone was applied once only at the time of surgery as a suspension. At days 3, 5, and 7 in the bFGF group, significant increases in the degree of re-epithelialization were found in treated groups. These results indicate that its action as a mitogen stimulus is the major effect of bFGF on salivary gland cells and mucosal epithelium.
Kagami
H
H
Department of Oral and Maxillofacial Surgery, Nagoya University, Postgraduate School of Medicine. kagami@hamon.swmed.edu
Hiramatsu
Y
Y
Hishida
S
S
Okazaki
Y
Y
Horie
K
K
Oda
Y
Y
Ueda
M
M
D000818:Animals; D001284:Atrophy; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004848:Epithelium / Q000187:drug effects / Q000293:injuries; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D009061:Mouth Mucosa / Q000187:drug effects / Q000293:injuries; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012038:Regeneration / Q000187:drug effects; D018987:Salivary Ducts / Q000187:drug effects / Q000473:pathology; D012466:Salivary Gland Diseases / Q000503:physiopathology*; D012469:Salivary Glands / Q000187:drug effects / Q000502:physiology*; D012965:Sodium Chloride; D018709:Statistics, Nonparametric; D013363:Submandibular Gland / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D013566:Sympathomimetics / Q000008:administration & dosage / Q000494:pharmacology; D014945:Wound Healing / Q000187:drug effects
D018809:Proliferating Cell Nuclear Antigen; D013566:Sympathomimetics; D016222:Fibroblast Growth Factor 2; D012965:Sodium Chloride; D007545:Isoproterenol